We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
-13.22%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.28B
AUM Growth
-$571M
(-20%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-7.02%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
985
New
54
Increased
140
Reduced
331
Closed
122
Avg Time Held
1.9
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$13.7M |
| 2 |
Coca-Cola
KO
|
+$10.7M |
| 3 |
CVS Health
CVS
|
+$9.84M |
| 4 |
Chart Industries
GTLS
|
+$4.3M |
| 5 |
Eaton
ETN
|
+$4.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$45.1M |
| 2 |
Apple
AAPL
|
+$17.6M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$15.8M |
| 4 |
Danaher
DHR
|
+$12.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.07% |
| 2 | Financials | 16.12% |
| 3 | Healthcare | 14.36% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Miscellaneous | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
AstraZeneca
AZN
$256B
| $13K | ﹤0.01% |
100
-154
| -61% | -$20.2K |
2021 Q4
2 quarters
|
|
652
Scotiabank
BNS
$111B
| $13K | ﹤0.01% |
223
| – | – |
2021 Q4
2 quarters
|
|
653
DELISTED
Enterprise Bancorp
EBTC
| $13K | ﹤0.01% |
400
| – | – |
2021 Q4
2 quarters
|
|
654
KeyCorp
KEY
$21.3B
| $13K | ﹤0.01% |
+752
| New | +$14.5K |
2022 Q2
0 quarters
|
|
655
Resideo Technologies
REZI
$2.51B
| $13K | ﹤0.01% |
682
| – | – |
2021 Q4
2 quarters
|
|
656
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.3B
| $13K | ﹤0.01% |
284
-5,572
| -95% | -$260K |
2022 Q1
1 quarter
|
|
657
Sun Communities
SUI
$14.3B
| $13K | ﹤0.01% |
79
| – | – |
2022 Q1
1 quarter
|
|
658
British American Tobacco
BTI
$129B
| $12K | ﹤0.01% |
281
| – | – |
2021 Q4
2 quarters
|
|
659
AB InBev
BUD
$162B
| $12K | ﹤0.01% |
+231
| New | +$13K |
2022 Q2
0 quarters
|
|
660
CDW
CDW
$18.8B
| $12K | ﹤0.01% |
79
+24
| +44% | +$4.04K |
2021 Q4
2 quarters
|
|
661
DELISTED
ChampionX
CHX
| $12K | ﹤0.01% |
625
| – | – |
2021 Q4
2 quarters
|
|
662
State Street SPDR S&P International Dividend ETF
DWX
$519M
| $12K | ﹤0.01% |
359
| – | – |
2021 Q4
2 quarters
|
|
663
Editas Medicine
EDIT
$366M
| $12K | ﹤0.01% |
1,000
| – | – |
2021 Q4
2 quarters
|
|
664
Eastman Chemical
EMN
$7.12B
| $12K | ﹤0.01% |
138
+32
| +30% | +$3.31K |
2021 Q4
2 quarters
|
|
665
iShares Select U.S. REIT ETF
ICF
$2.08B
| $12K | ﹤0.01% |
200
| – | – |
2021 Q4
2 quarters
|
|
666
Nordson
NDSN
$17.8B
| $12K | ﹤0.01% |
57
| – | – |
2022 Q1
1 quarter
|
|
667
RBC Bearings
RBC
$15.7B
| $12K | ﹤0.01% |
66
| – | – |
2022 Q1
1 quarter
|
|
668
Welltower
WELL
$169B
| $12K | ﹤0.01% |
150
| – | – |
2021 Q4
2 quarters
|
|
669
Black Hills Corp
BKH
$5.85B
| $11K | ﹤0.01% |
147
| – | – |
2021 Q4
2 quarters
|
|
670
Centene
CNC
$34.4B
| $11K | ﹤0.01% |
135
-80
| -37% | -$6.64K |
2021 Q4
2 quarters
|
|
671
Capital Southwest
CSWC
$1.47B
| $11K | ﹤0.01% |
600
| – | – |
2021 Q4
2 quarters
|
|
672
Edison International
EIX
$21.5B
| $11K | ﹤0.01% |
179
| – | – |
2021 Q4
2 quarters
|
|
673
VanEck Junior Gold Miners ETF
GDXJ
$8.11B
| $11K | ﹤0.01% |
331
| – | – |
2021 Q4
2 quarters
|
|
674
Goodyear
GT
$1.23B
| $11K | ﹤0.01% |
1,050
| – | – |
2021 Q4
2 quarters
|
|
675
Robinhood
HOOD
$88.7B
| $11K | ﹤0.01% |
1,300
| – | – |
2021 Q4
2 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Cambridge Trust held 985 positions worth $2.28B, down 20% from $2.86B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Cambridge Trust withdrew a net $160M in Q2 2022, closing 122 positions and reducing 331 holdings. Its most notable exit was Paycom, an estimated $915K position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cambridge Trust opened a new position in Chart Industries worth $4.21M.
- Cambridge Trust's largest Q2 2022 buy was Chart Industries: 25,166 shares worth $4.21M.
- Cambridge Trust added most to ExxonMobil in Q2 2022, an estimated $13.7M increase.
- Cambridge Trust's biggest Q2 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $45.1M.
- Cambridge Trust fully exited Paycom in Q2 2022, selling an estimated $915K.
- Cambridge Trust's ten largest holdings make up 27% of its $2.28B portfolio in Q2 2022.
- Cambridge Trust opened 54 new positions and closed 122 in Q2 2022.
- Cambridge Trust's portfolio value fell 20% quarter-over-quarter to $2.28B.
Based on Cambridge Trust's 13F filing for Q2 2022, filed 16 Aug 2022.